Overview | UPTRAVI® (selexipag)

Back to Janssen Medical Cloud

Efficacy
Safety and tolerability
Initiation and dosing
Expert consensus
Resources

CP-415426 - October 2023

J-C Health Care Ltd. – Janssen Israel, Kibbutz Sheffayim 6099000, fax 09-9583636 info-janssen@its.jnj.com

מדיניות פרטיות מידע משפטי